21 – 29 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2017
-
Mark
Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease : Dawn of a New Era
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
GFORCE-PD still going strong in 2016
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Comparability : Manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015
(
- Contribution to journal › Article
-
Mark
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease : involvement of astrocyte-neuron interactions
(
- Contribution to journal › Article
-
Mark
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
(
- Contribution to journal › Article
-
Mark
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
(
- Contribution to journal › Article
- 2015
-
Mark
Cell-based therapies for Parkinson disease-past insights and future potential.
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »